文献速递系统性红斑狼疮其他结缔组织病

羟氯喹与子痫前期:多种族系统性红斑狼疮女性队列研究

Hydroxychloroquine and Pre-eclampsia in a Diverse Cohort of Women With Systemic Lupus Erythematosus.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2024-08-09

在凯撒北加州医疗系统2011至2020年324例系统性红斑狼疮患者的399次妊娠中,评估孕前3个月至早孕期羟氯喹暴露与子痫前期或子痫的关联。采用倾向性评分和改良泊松模型,多种暴露定义下均未发现显著关联;初产妇风险比 consistently 较低,高危亚组(肾炎史、抗磷脂抗体阳性或孕前高血压)风险比呈保护性但未达统计学显著。

要点

  • 在324例系统性红斑狼疮患者的399次妊娠中,多种羟氯喹暴露定义下与子痫前期或子痫的关联均为无效关联。
  • 初产妇中风险比 consistently 较低;高危亚组(肾炎史、抗磷脂抗体阳性或孕前高血压)风险比呈保护性但未达统计学显著。
  • 作者认为尽管在整合医疗系统且临床数据详细的环境下,残余混杂可能削弱了效应。

核心结论

  • 本研究未发现羟氯喹降低子痫前期或子痫风险,但作者指出残余混杂可能削弱效应。

研究设计与样本

  • 基于凯撒北加州医疗系统2011至2020年324例系统性红斑狼疮患者的399次妊娠的队列研究。
  • 羟氯喹暴露定义为孕前3个月至早孕期,采用多种定义以考虑依从性和治疗时长。
  • 使用倾向性评分控制多个混杂因素,改良泊松模型估计风险比(RR)及95%置信区间。
  • 通过分层分析探讨孕前高血压、肾炎史和抗磷脂抗体(aPL)状态的效应修饰。

主要发现

  • 在多种暴露定义下,羟氯喹与子痫前期或子痫的关联均为无效关联。
  • 初产妇中风险比 consistently 较低。
  • 在高危亚组(肾炎史、aPL阳性或孕前高血压)中,无论初产妇还是经产妇,风险比 consistently 呈保护性但未达统计学显著。

局限性

  • 作者指出残余混杂可能削弱效应,尽管研究在整合医疗系统且临床数据详细的环境下进行。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with systemic lupus erythematosus (SLE) are at risk for pregnancy complications such as pre-eclampsia and eclampsia. These clinically important complications are associated with maternal morbidity, mortality, and postpartum cardiovascular disease. Some studies suggest that hydroxychloroquine (HCQ) may reduce pre-eclampsia risk in lupus pregnancy. Using a cohort of pregnant patients with prevalent SLE at Kaiser Permanente Northern California (KPNC), we investigated whether HCQ treatment in early pregnancy reduced the risk of pre-eclampsia or eclampsia. METHODS: Among pregnant patients with SLE from 2011 to 2020, we assessed HCQ treatment from three months before pregnancy through the first trimester. HCQ exposure was defined multiple ways to account for adherence and duration of treatment. Propensity scores accounted for multiple confounders and modified Poisson models estimated risk ratios (RRs) and 95% confidence intervals of the association between HCQ treatment and pre-eclampsia or eclampsia. Effect modification by pregestational hypertension, history of nephritis, and antiphospholipid antibody (aPL) status was investigated through stratified analysis. RESULTS: There were 399 pregnancies among 324 patients with SLE at KPNC between 2011 and 2020. Considering multiple exposure definitions, we consistently found a null association between HCQ and pre-eclampsia or eclampsia. The RRs were consistently lower among nullipara patients, and RRs were consistently protective but not statistically significant among the high-risk subgroup of patients with a history of nephritis, aPL positivity, or pregestational hypertension (for both nullipara and multipara patients). CONCLUSION: Although this study found no reduced risk of HCQ on pre-eclampsia or eclampsia, residual confounding may be attenuating the effect despite an integrated health care delivery system setting with detailed clinical data.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Simard JF, Liu EF, Rector A, et al. Hydroxychloroquine and Pre-eclampsia in a Diverse Cohort of Women With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2024. PMID: 38926748. doi:10.1002/acr.25386

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。